HealthTech

uniQure

uniQure raises $345M Public Offering

$345M

Total Raised

Public Offering

Latest Round

1998

Founded

600+

Employees

Amsterdam, Netherlands

Updated September 8, 2025

1 min read

Quick Facts

Latest Round Size

$345M

Latest Round Date

September 2025

uniQure: Public Offering Funding Round

uniQure has successfully raised $345M in Public Offering funding.

Company Overview

Gene therapy company developing AMT-130 for Huntington's disease treatment

Funding Details

The Public Offering round was led by Public Markets.

Investment

uniQure plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

Public Markets: Verified investor in Public Offering

Key Investors

Public Markets

Lead Investor

Verified investor in Public Offering

Topics

verified(1243)real-funding(1243)healthtech(156)amsterdam(20)public-offering(4)uniqure(1)

About the Author

Editorial Team

Curated funding news from verified sources

Related Company Reports

HealthTech

AccelerateStack Platform

AccelerateStack Platform raises $75M Series C at $226M valuation

AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.

DermaSensor raises $16M Series B at $85M valuation

DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...

Devoted Health Partners

Devoted Health Partners Headquarters - Office Location & Address

Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.